molecular based analysis and novel therapies development of chronic myelocytic leukemia

molecular based analysis and novel therapies development of chronic myelocytic leukemia - molecular based analysis and novel therapies development of chronic myelocytic leukemia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015409

Enrollment

200

Registered

2014-10-14

Start date

2014-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic myelocytic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic myelocytic leukemia patient who are treated by Keio University

Exclusion criteria

Exclusion criteria: 1 Can not consent in writing 2 physician deems disqualify

Design outcomes

Primary

Measure	Time frame
copy number ob BCR-ABL in PCR	—

Countries

Japan

Contacts

Public ContactDaiki Karigane

Keio University School of Medicine Division of Hematology

karigane@hotmail.com03-3353-1211

Outcome results